all new and
to the McGill
Faculty of Medicine!
Adverse effects of diabetes drugs
Two studies led by Dr. Laurent Azoulay, Associate Prof. in the Dept. of EBOH and the Gerald Bronfman Dept. of Oncology at McGill and Senior Investigator at the LDI at the JGH, discovered that Incretin-based drugs for type 2 diabetes are not associated with an increased risk of acute pancreatitis but do increase risk of bile duct and gallbladder disease.
“Big Data” study discovers earliest sign of Alzheimer’s
Led by Dr. Alan Evans, professor of neurology, neurosurgery and biomedical engineering at the Neuro, a team of researchers has used a powerful tool to better understand the progression of late-onset Alzheimer’s disease, identifying its first physiological signs.
Researchers in the lab of Dr. Christopher Pack at the Neuro found, in a new study, that as visual stimuli size increases, so too does the neural “noise” produced. Understanding the noise suppression process could help researchers find ways to compensate for brain impairments and improve vision.
A recent study by Natasha Rajah, Associate Professor in McGill’s Department of Psychiatry & Director of the Brain Imaging Centre at Douglas Institute, and a team of McGill researchers, has revealed that the inability to remember details may be the result of a change in what the brain focuses on during memory formation and retrieval, rather than a decline in brain function.
Gerald Batist appointed Knight of the Order of Quebec
The Faculty of Medicine’s Dr. Gerald Batist, Director of the Segal Cancer Centre, clinical oncologist and pioneer in personalized medicine was among the seven McGillians named to the National Order of Quebec, the highest civilian honour in the province.
You’re ill. You visit a doctor who examines you, diagnoses you with a once deadly cancer, immediately offers some non-invasive treatment, and sends you home with a good prognosis, relatively free of pain and side effects. It’s a scene straight out of Star Trek, but it might not be too far from reality.